Posted by Michael Wonder on 04 Jan 2023
Drug makers to raise prices on at least 350 drugs in US in January
31 December 2022 - Drug makers including Pfizer, GSK, BMS, AstraZeneca and Sanofi plan to raise prices in the US on more than 350 unique drugs in early January, according to data analysed by health care research firm 3 Axis Advisors.
The increases are expected to come as the pharmaceutical industry prepares for the Biden Administration's Inflation Reduction Act, which allows the government's Medicare health program to negotiate prices directly for some drugs starting in 2026. The industry is also contending with inflation and supply chain constraints that have led to higher manufacturing costs.
